Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Here's How Much You'd Have If You Invested $1000 in Cigna a Decade Ago

By Zacks Investment ResearchStock MarketsJan 18, 2022 08:30PM ET
www.investing.com/analysis/heres-how-much-youd-have-if-you-invested-1000-in-cigna-a-decade-ago-200615244
Here's How Much You'd Have If You Invested $1000 in Cigna a Decade Ago
By Zacks Investment Research   |  Jan 18, 2022 08:30PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries.

The fear of missing out, or FOMO, also plays a factor in investing, especially with particular tech giants, as well as popular consumer-facing stocks.

What if you'd invested in Cigna (CI) ten years ago? It may not have been easy to hold on to CI for all that time, but if you did, how much would your investment be worth today?

Cigna's Business In-Depth

With that in mind, let's take a look at Cigna's main business drivers.

Headquartered in Bloomfield, CT and formed in 1982, Cigna Corp. is the result of a merger between Connecticut General Life Insurance Company and Insurance Company of North America. Cigna completed its combination with Express Scripts Holding Company (NASDAQ:ESRX) by 2018-end. Shares of the new combined company have started trading on the NYSE under the stock ticker symbol “CI.”

The health service company updated its segment names to align with the launch of Evernorth and to better reflect a suite of services offered across its portfolio. With divesting its life, accident and supplemental benefits businesses to Chubb (NYSE:CB) for $5.75 billion, it intends to focus more on the profitable global health services portfolio. The segment previously reported as Health Services is now reported as Evernorth and the segment previously reported as Integrated Medical is now reported as U.S Medical. There are no changes to the underlying businesses reported in either segment.

Evernorth (constitutes 72% of total revenues in 2020) includes a broad range of coordinated and point solution health services, including pharmacy services, benefits management, care solutions and data and analytics, which are provided to health plans, employers, government organizations, and health care providers.

U.S. Medical (24%) offers a variety of health care solutions to employers and individuals. Its sub-segment, the U.S. Commercial operating unit serves employers and their employees and other groups. This segment's products and services include medical, pharmacy, dental, behavioral health, vision, health advocacy programs and other products and services. Another sub-segment, the U.S. Government operating unit offers Medicare Advantage, Medicare Supplement and Medicare Part D plans for seniors (including the acquired Express Scripts' Medicare Part D business), Medicaid plans, and individual health insurance plans both on and off the public exchanges.

International Markets (4%) includes supplemental health, life and accident insurance products and health care coverage in the company’s international markets, as well as health care benefits to globally mobile employees of multinational organizations.

Bottom Line

Anyone can invest, but building a successful investment portfolio takes a combination of a few things: research, patience, and a little bit of risk. So, if you had invested in Cigna a decade ago, you're probably feeling pretty good about your investment today.

A $1000 investment made in January 2012 would be worth $5,112.48, or a gain of 411.25%, as of January 19, 2022, according to our calculations. This return excludes dividends but includes price appreciation.

The S&P 500 rose 249.92% and the price of gold increased 5.07% over the same time frame in comparison.

Analysts are forecasting more upside for CI too.

Cigna's revenues have been increasing consistently for the past several years. Its buyout of Express Scripts diversified its business by adding pharmacy benefits to the insurance operations. Business streamlining by divesting Group Life and Disability insurance business will help it focus on core growth areas. An expected increase in medical membership bodes well. In 2021, the company anticipates deploying over $7 billion to shareholders through share repurchase and dividend payments. Its shares have outperformed the industry in a year. However, high leverage is a concern for Cigna, affecting financial flexibility. Also, rising operating costs might dent its margins. Declining cash flow is worrisome. For 2021, the firm expects at least $7.5 billion of cash flow from operations, which indicates a decline of 27.5% from the 2020 reported number.

The stock has jumped 8.96% over the past four weeks. Additionally, no earnings estimate has gone lower in the past two months, compared to 1 higher, for fiscal 2021; the consensus estimate has moved up as well.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +25.3% per year. So be sure to give these hand-picked 7 your immediate attention.

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cigna Corporation (NYSE:CI): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Here's How Much You'd Have If You Invested $1000 in Cigna a Decade Ago
 

Related Articles

Here's How Much You'd Have If You Invested $1000 in Cigna a Decade Ago

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email